We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Li–Fraumeni syndrome heterogeneity.
- Authors
Gargallo, P.; Yáñez, Y.; Segura, V.; Juan, A.; Torres, B.; Balaguer, J.; Oltra, S.; Castel, V.; Cañete, A.
- Abstract
Clinical variability is commonly seen in Li–Fraumeni syndrome. Phenotypic heterogeneity is present among different families affected by the same pathogenic variant in TP53 gene and among members of the same family. However, causes of this huge clinical spectrum have not been studied in depth. TP53 type mutation, polymorphic variants in TP53 gene or in TP53-related genes, copy number variations in particular regions, and/or epigenetic deregulation of TP53 expression might be responsible for clinical heterogeneity. In this review, recent advances in the understanding of genetic and epigenetic aspects influencing Li–Fraumeni phenotype are discussed.
- Publication
Clinical & Translational Oncology, 2020, Vol 22, Issue 7, p978
- ISSN
1699-048X
- Publication type
Article
- DOI
10.1007/s12094-019-02236-2